McKinsey December 15, 2018
When patients fail to follow prescribed medical regimens, outcomes suffer. A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue.
Failure to adhere to prescribed-medication regimens is one of the principal reasons patients don’t achieve the expected outcomes from their treatment. Solving this challenge has been a major goal for pharmaceutical and healthcare organizations for decades. Studies show that 50 to 60 percent of patients with chronic illnesses miss doses, take the wrong doses, or drop off treatment in the first year.1 An estimated 125,000 lives are lost annually in the United States and additional healthcare expenditures of $290 billion are driven by nonadherence.2 An estimated 10 percent of hospitalizations in older patients are...
Today's Sponsors
Today's Sponsor